Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

ESUR prostate MR guidelines 2012.

Barentsz JO, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G, Rouviere O, Logager V, Fütterer JJ; European Society of Urogenital Radiology.

Eur Radiol. 2012 Apr;22(4):746-57. doi: 10.1007/s00330-011-2377-y. Epub 2012 Feb 10.

2.

A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion.

Hadaschik BA, Kuru TH, Tulea C, Rieker P, Popeneciu IV, Simpfendörfer T, Huber J, Zogal P, Teber D, Pahernik S, Roethke M, Zamecnik P, Roth W, Sakas G, Schlemmer HP, Hohenfellner M.

J Urol. 2011 Dec;186(6):2214-20. doi: 10.1016/j.juro.2011.07.102. Epub 2011 Oct 19.

PMID:
22014798
3.

Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds.

Turkbey B, Mani H, Shah V, Rastinehad AR, Bernardo M, Pohida T, Pang Y, Daar D, Benjamin C, McKinney YL, Trivedi H, Chua C, Bratslavsky G, Shih JH, Linehan WM, Merino MJ, Choyke PL, Pinto PA.

J Urol. 2011 Nov;186(5):1818-24. doi: 10.1016/j.juro.2011.07.013. Epub 2011 Sep 25.

4.

Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort.

Hambrock T, Hoeks C, Hulsbergen-van de Kaa C, Scheenen T, Fütterer J, Bouwense S, van Oort I, Schröder F, Huisman H, Barentsz J.

Eur Urol. 2012 Jan;61(1):177-84. doi: 10.1016/j.eururo.2011.08.042. Epub 2011 Aug 27.

PMID:
21924545
5.

Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging.

Pinto PA, Chung PH, Rastinehad AR, Baccala AA Jr, Kruecker J, Benjamin CJ, Xu S, Yan P, Kadoury S, Chua C, Locklin JK, Turkbey B, Shih JH, Gates SP, Buckner C, Bratslavsky G, Linehan WM, Glossop ND, Choyke PL, Wood BJ.

J Urol. 2011 Oct;186(4):1281-5. doi: 10.1016/j.juro.2011.05.078. Epub 2011 Aug 17.

6.

Active surveillance for prostate cancer: progress and promise.

Cooperberg MR, Carroll PR, Klotz L.

J Clin Oncol. 2011 Sep 20;29(27):3669-76. doi: 10.1200/JCO.2011.34.9738. Epub 2011 Aug 8. Review.

7.

Office based transrectal saturation biopsy improves prostate cancer detection compared to extended biopsy in the repeat biopsy population.

Zaytoun OM, Moussa AS, Gao T, Fareed K, Jones JS.

J Urol. 2011 Sep;186(3):850-4. doi: 10.1016/j.juro.2011.04.069. Epub 2011 Jul 23.

PMID:
21788047
8.

Clinical application of a 3D ultrasound-guided prostate biopsy system.

Natarajan S, Marks LS, Margolis DJ, Huang J, Macairan ML, Lieu P, Fenster A.

Urol Oncol. 2011 May-Jun;29(3):334-42. doi: 10.1016/j.urolonc.2011.02.014.

9.

Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer.

Hambrock T, Somford DM, Huisman HJ, van Oort IM, Witjes JA, Hulsbergen-van de Kaa CA, Scheenen T, Barentsz JO.

Radiology. 2011 May;259(2):453-61. doi: 10.1148/radiol.11091409.

PMID:
21502392
10.

Active surveillance program for prostate cancer: an update of the Johns Hopkins experience.

Tosoian JJ, Trock BJ, Landis P, Feng Z, Epstein JI, Partin AW, Walsh PC, Carter HB.

J Clin Oncol. 2011 Jun 1;29(16):2185-90. doi: 10.1200/JCO.2010.32.8112. Epub 2011 Apr 4.

PMID:
21464416
11.

Focal therapy for localized prostate cancer: a phase I/II trial.

Ahmed HU, Freeman A, Kirkham A, Sahu M, Scott R, Allen C, Van der Meulen J, Emberton M.

J Urol. 2011 Apr;185(4):1246-54. doi: 10.1016/j.juro.2010.11.079. Epub 2011 Feb 22.

PMID:
21334018
12.

D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging.

Rastinehad AR, Baccala AA Jr, Chung PH, Proano JM, Kruecker J, Xu S, Locklin JK, Turkbey B, Shih J, Bratslavsky G, Linehan WM, Glossop ND, Yan P, Kadoury S, Choyke PL, Wood BJ, Pinto PA.

J Urol. 2011 Mar;185(3):815-20. doi: 10.1016/j.juro.2010.10.076. Epub 2011 Jan 15.

13.

Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?

Turkbey B, Shah VP, Pang Y, Bernardo M, Xu S, Kruecker J, Locklin J, Baccala AA Jr, Rastinehad AR, Merino MJ, Shih JH, Wood BJ, Pinto PA, Choyke PL.

Radiology. 2011 Feb;258(2):488-95. doi: 10.1148/radiol.10100667. Epub 2010 Dec 21.

14.

Outcomes of active surveillance for men with intermediate-risk prostate cancer.

Cooperberg MR, Cowan JE, Hilton JF, Reese AC, Zaid HB, Porten SP, Shinohara K, Meng MV, Greene KL, Carroll PR.

J Clin Oncol. 2011 Jan 10;29(2):228-34. doi: 10.1200/JCO.2010.31.4252. Epub 2010 Nov 29.

15.

Time trends and local variation in primary treatment of localized prostate cancer.

Cooperberg MR, Broering JM, Carroll PR.

J Clin Oncol. 2010 Mar 1;28(7):1117-23. doi: 10.1200/JCO.2009.26.0133. Epub 2010 Feb 1.

16.

Importance of additional "extreme" anterior apical needle biopsies in the initial detection of prostate cancer.

Moussa AS, Meshref A, Schoenfield L, Masoud A, Abdel-Rahman S, Li J, Flazoura S, Magi-Galluzzi C, Fergany A, Fareed K, Jones JS.

Urology. 2010 May;75(5):1034-9. doi: 10.1016/j.urology.2009.11.008. Epub 2010 Jan 18.

PMID:
20080294
17.

Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen.

Hambrock T, Somford DM, Hoeks C, Bouwense SA, Huisman H, Yakar D, van Oort IM, Witjes JA, Fütterer JJ, Barentsz JO.

J Urol. 2010 Feb;183(2):520-7. doi: 10.1016/j.juro.2009.10.022. Epub 2009 Dec 14.

PMID:
20006859
18.

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer.

Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A.

J Clin Oncol. 2010 Jan 1;28(1):126-31. doi: 10.1200/JCO.2009.24.2180. Epub 2009 Nov 16.

PMID:
19917860
19.

Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting.

Taira AV, Merrick GS, Galbreath RW, Andreini H, Taubenslag W, Curtis R, Butler WM, Adamovich E, Wallner KE.

Prostate Cancer Prostatic Dis. 2010 Mar;13(1):71-7. doi: 10.1038/pcan.2009.42. Epub 2009 Sep 29.

20.

Mechanically assisted 3D ultrasound guided prostate biopsy system.

Bax J, Cool D, Gardi L, Knight K, Smith D, Montreuil J, Sherebrin S, Romagnoli C, Fenster A.

Med Phys. 2008 Dec;35(12):5397-410.

PMID:
19175099

Supplemental Content

Support Center